Target of Rapamycin (TOR)–Based Therapy for Cardiomyopathy: Evidence From Zebrafish and Human Studies
Trends in Cardiovascular Medicine - Netherlands
doi 10.1016/j.tcm.2012.06.009
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
Elsevier BV